Theo Hatzipetros

Theo Hatzipetros Email and Phone Number

Senior Director Of Pharmacology at ALS Therapy Development Institute @ ALS Therapy Development Institute
Theo Hatzipetros's Location
Cambridge, Massachusetts, United States, United States
Theo Hatzipetros's Contact Details

Theo Hatzipetros work email

Theo Hatzipetros personal email

n/a
About Theo Hatzipetros

Neuropharmacologist with a strong in vivo background in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD). Expertise in the preclinical evaluation of experimental therapeutics, in developing and characterizing animal models of neurological diseases and in the identification of disease-relevant biomarkers.

Theo Hatzipetros's Current Company Details
ALS Therapy Development Institute

Als Therapy Development Institute

View
Senior Director Of Pharmacology at ALS Therapy Development Institute
Theo Hatzipetros Work Experience Details
  • Als Therapy Development Institute
    Senior Director Of Pharmacology
    Als Therapy Development Institute Jan 2024 - Present
    Watertown, Massachusetts, Us
  • Als Therapy Development Institute
    Director Of Pharmacology
    Als Therapy Development Institute Jan 2019 - Jan 2024
    Watertown, Massachusetts, Us
  • Als Therapy Development Institute
    Senior Scientist
    Als Therapy Development Institute Jan 2017 - Dec 2018
    Watertown, Massachusetts, Us
    o Led internal small molecule pharmacology projects largely focused on targeting ER stress and the UPR pathways. o Managed fee-for-service pharmacology projects involving small and large molecule therapeutics.o Served as contact person with CRO's as well as industry and academic collaborators.o Led efforts to secure funding through RO1 and DOD research grant proposals.
  • Als Therapy Development Institute
    Scientist Ii
    Als Therapy Development Institute 2013 - Dec 2016
    Watertown, Massachusetts, Us
    o Supervised the in vivo pharmacology team on the execution of PK/PD, tolerability and drug efficacy studies in mice.o Served as a principal investigator on IACUC protocols.o Authored scientific peer-reviewed publications, contributed content to the institute’s website, presented study findings to ALS TDI stakeholders.
  • Als Therapy Development Institute
    Scientist I
    Als Therapy Development Institute 2011 - 2013
    Watertown, Massachusetts, Us
    o Led the development and characterization of nearly a dozen novel transgenic mouse models of ALS (TDP43, TAF15, several SOD1 mutants, C9orf etc.).o Developed behavioral and biochemical assays for drug screening and target validation. o Contributed in the development of techniques used to quantify protein misfolding and aggregate load in transgenic SOD1-overexpressing mice.
  • Foldrx Pharmaceuticals
    Scientist, Parkinson'S Disease Group
    Foldrx Pharmaceuticals 2008 - 2010
    Us
    o Designed and executed drug efficacy studies in the targeted AAV1/2-a synuclein overexpression rat model of PD.o Developed formulations enabling the safe and efficient administration of novel drugs to mice.o Performed cell-based drug screening assays.o Responsible for hiring and managing research interns and part-time staff. o Wrote protocols to ensure compliance with IACUC policies and procedures.o Provided oversight of the day-to-day operations of the animal facility on matters related to animal care and health, safety issues, regulation compliance.
  • Foldrx Pharmaceuticals
    Post-Doctoral Fellow, Parkinson'S Disease Group
    Foldrx Pharmaceuticals 2007 - 2008
    Us
    o Optimized the AAV1/2-a-synuclein transgene overexpression rat model by identifying biomarkers and disease-relevant endpoints that were used to monitor the disease progression and to assess compound efficacy for the treatment of PD.

Theo Hatzipetros Skills

Animal Models Assay Development Neuroscience Pharmacology Drug Development Immunohistochemistry Pk/pd Hplc Biomarkers Biotechnology Clinical Research R&d Animal Surgery In Vivo Microdialysis Protein Misfolding Voltammetry Scientific Writing Molecular Biology Clinical Development Life Sciences In Vivo

Theo Hatzipetros Education Details

  • Boston University School Of Medicine
    Boston University School Of Medicine
    Pharmacology
  • Boston College Carroll School Of Management
    Boston College Carroll School Of Management
    Health And Pharma Concentration
  • Illinois State University
    Illinois State University
    Neuroscience
  • Adelphi University
    Adelphi University
    Minor: Anthropology
  • The English School, Nicosia
    The English School, Nicosia
    Highschool Diploma

Frequently Asked Questions about Theo Hatzipetros

What company does Theo Hatzipetros work for?

Theo Hatzipetros works for Als Therapy Development Institute

What is Theo Hatzipetros's role at the current company?

Theo Hatzipetros's current role is Senior Director Of Pharmacology at ALS Therapy Development Institute.

What is Theo Hatzipetros's email address?

Theo Hatzipetros's email address is ha****@****drx.com

What schools did Theo Hatzipetros attend?

Theo Hatzipetros attended Boston University School Of Medicine, Boston College Carroll School Of Management, Illinois State University, Adelphi University, The English School, Nicosia.

What skills is Theo Hatzipetros known for?

Theo Hatzipetros has skills like Animal Models, Assay Development, Neuroscience, Pharmacology, Drug Development, Immunohistochemistry, Pk/pd, Hplc, Biomarkers, Biotechnology, Clinical Research, R&d.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.